論文

査読有り 最終著者 責任著者 国際誌
2018年12月

A single-arm pilot study of guided self-help treatment based cognitive behavioral therapy for bulimia nervosa in Japanese clinical settings

BMC Research Notes
  • R. Setsu
  • K. Asano
  • N. Numata
  • M. Tanaka
  • H. Ibuki
  • T. Yamamoto
  • R. Uragami
  • J. Matsumoto
  • Y. Hirano
  • M. Iyo
  • E. Shimizu
  • M. Nakazato
  • 全て表示

11
1
開始ページ
257
終了ページ
257
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1186/s13104-018-3373-y
出版者・発行元
Springer Science and Business Media LLC

OBJECTIVE: Guided self-help treatments based on cognitive behavioral therapy (CBT-GSH) are regarded as a first-line effective treatment for bulimia nervosa (BN). With limited application for CBT-GSH in Japanese clinical settings, we conducted a single arm pilot study in order to confirm the acceptability and availability of CBT-GSH in Japan. RESULTS: 25 women with BN received 16-20 sessions of face-to-face CBT-GSH. Primary outcomes were the completion rate of intervention and abstinence rates from objective bingeing and purging as assessed by the Eating Disorder Examination. Secondary outcomes were other self-report measurements of the frequency of bingeing and purging, and characteristic psychopathologies of eating disorders. Assessments were conducted before CBT as baseline as well as after CBT. 92% (23/25) of the participants completed the CBT sessions. After CBT-GSH, 40% (10/25) of the participants (intention-to-treat) achieved symptom abstinence. The mean binge and purge episodes during the previous 28 days improved from 21.88 to 10.96 (50% reduction) and from 22.44 to 10.88 (52% reduction), each (before CBT-GSH to after CBT-GSH), and the within-group effect sizes were medium (Cohen's d = 0.67, 0.65, each). Our study provided a preliminary evidence about the feasibility of CBT-GSH in Japanese clinical settings for the future. Trial registration This study was registered retrospectively in the national UMIN Clinical Trials Registry on July 10, 2013 (registration ID: UMIN000011120).

リンク情報
DOI
https://doi.org/10.1186/s13104-018-3373-y
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/29695260
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918895
URL
http://link.springer.com/content/pdf/10.1186/s13104-018-3373-y.pdf
URL
http://link.springer.com/article/10.1186/s13104-018-3373-y/fulltext.html
ID情報
  • DOI : 10.1186/s13104-018-3373-y
  • eISSN : 1756-0500
  • PubMed ID : 29695260
  • PubMed Central 記事ID : PMC5918895

エクスポート
BibTeX RIS